Arden Trust CO Abb Vie Inc. Transaction History

Arden Trust CO

$683 Million
Q2 2024

A detailed history of Arden Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Arden Trust CO holds 6,819 shares of ABBV stock, worth $1.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

6,819

Previous 6,835 0.23%

Holding current value

$1.2 Million

Previous $1.24 Million 6.03%

% of portfolio

0.17%

Previous 0.18%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$154.79 - $180.76 $2,476 - $2,892	-16 Reduced 0.23%	6,819 $1.17 Million
Q1 2024 Apr 03, 2024	SELL	$159.82 - $182.1 $22,854 - $26,040	-143 Reduced 2.05%	6,835 $1.24 Million
Q4 2023 Jan 04, 2024	SELL	$137.6 - $154.97 $67,561 - $76,090	-491 Reduced 6.57%	6,978 $1.08 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $148,284 - $171,661	-1,110 Reduced 12.94%	7,469 $1.11 Million
Q2 2023 Jul 14, 2023	SELL	$132.51 - $164.9 $538,388 - $669,988	-4,063 Reduced 32.14%	8,579 $1.16 Million
Q1 2023 Apr 14, 2023	SELL	$144.61 - $166.54 $291,244 - $335,411	-2,014 Reduced 13.74%	12,642 $2.01 Million
Q4 2022 Jan 20, 2023	SELL	$138.31 - $165.87 $40,801 - $48,931	-295 Reduced 1.97%	14,656 $0
Q3 2022 Oct 20, 2022	BUY	$134.21 - $153.93 $82,807 - $94,974	617 Added 4.3%	14,951 $2.01 Million
Q2 2022 Jul 12, 2022	BUY	$137.62 - $174.96 $1.97 Million - $2.51 Million	14,334 New	14,334 $2.2 Million
Q1 2022 Apr 11, 2022	SELL	$131.98 - $163.75 $2.61 Million - $3.23 Million	-19,750 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $25,031 - $31,671	-233 Reduced 1.17%	19,750 $2.67 Million
Q3 2021 Oct 12, 2021	SELL	$106.4 - $120.78 $89,482 - $101,575	-841 Reduced 4.04%	19,983 $2.16 Million
Q2 2021 Jul 19, 2021	SELL	$105.21 - $117.21 $203,160 - $226,332	-1,931 Reduced 8.49%	20,824 $2.35 Million
Q1 2021 Apr 23, 2021	BUY	$102.3 - $112.62 $59,640 - $65,657	583 Added 2.63%	22,755 $2.46 Million
Q4 2020 Jan 15, 2021	SELL	$80.49 - $108.67 $29,620 - $39,990	-368 Reduced 1.63%	22,172 $2.38 Million
Q3 2020 Oct 15, 2020	SELL	$85.91 - $100.83 $97,593 - $114,542	-1,136 Reduced 4.8%	22,540 $1.97 Million
Q2 2020 Jul 09, 2020	BUY	$73.37 - $98.18 $929,010 - $1.24 Million	12,662 Added 114.96%	23,676 $2.32 Million
Q1 2020 Apr 16, 2020	SELL	$64.5 - $97.79 $87,978 - $133,385	-1,364 Reduced 11.02%	11,014 $839,000
Q4 2019 Jan 17, 2020	SELL	$72.13 - $90.25 $336,125 - $420,565	-4,660 Reduced 27.35%	12,378 $1.1 Million
Q3 2019 Oct 09, 2019	SELL	$62.98 - $75.72 $119,410 - $143,565	-1,896 Reduced 10.01%	17,038 $1.29 Million
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $1.24 Million - $1.59 Million	18,934 New	18,934 $1.38 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Arden Trust CO with notifications on news.

Account